This compound finds application in the field of medicinal chemistry, particularly in the development of glycosidase inhibitors. Its unique structure, combining a thiourea moiety with a glucopyranosyl group, allows it to interact effectively with enzyme active sites, making it a potential candidate for treating diseases related to carbohydrate metabolism, such as diabetes. Additionally, its diphenyl and pyrrolidinyl components contribute to its ability to bind selectively to biological targets, enhancing its potential as a therapeutic agent. Researchers also explore its use in the synthesis of complex glycoconjugates, which are valuable in studying cell-surface interactions and developing targeted drug delivery systems.